Clinical Trials
13
Active:1
Completed:5
Trial Phases
3 Phases
Phase 1:2
Phase 3:3
Not Applicable:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Not Applicable
5 (50.0%)Phase 3
3 (30.0%)Phase 1
2 (20.0%)Effect of Oxygen Supplementation on Cerebral Oxygenation, Symptoms and Performance During STST in COPD Patients
Not Applicable
Active, not recruiting
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- First Posted Date
- 2025-06-17
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- George Papanicolaou Hospital
- Target Recruit Count
- 25
- Registration Number
- NCT07024914
- Locations
- 🇬🇷
Papanikolaou General Hospital, Thessaloniki, Greece
Cardiac Index, SVR/SVRI During Weaning From ECC- Data Obtained From Femoral and Radial Artery Transducer
Not Applicable
Not yet recruiting
- Conditions
- Coronary Artery DiseaseMitral Valve DiseaseAortic Valve Disease
- First Posted Date
- 2023-11-01
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- George Papanicolaou Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT06112561
T Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus Fumigatus Infections After Allogeneic Stem Cell Transplantation
Phase 1
Completed
- Conditions
- Opportunistic Viral InfectionBone Marrow Transplant InfectionOpportunistic Fungal Infection
- Interventions
- First Posted Date
- 2022-07-25
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- George Papanicolaou Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT05471661
- Locations
- 🇬🇷
University General Hospital of Patras, Patra, Greece
🇬🇷George Papanikolaou Hospital - Gene and Cell Therapy Center- Hematology Dpt- Hematopoietic Stem Cell Transplant Center, Thessaloníki, Greece
Generation of SARS-CoV-2-specific T Lymphocytes From Recovered Donors and Administration to High-risk COVID-19 Patients
Phase 1
Recruiting
- Conditions
- Severe COVID-19
- First Posted Date
- 2022-07-07
- Last Posted Date
- 2022-11-23
- Lead Sponsor
- George Papanicolaou Hospital
- Target Recruit Count
- 182
- Registration Number
- NCT05447013
- Locations
- 🇬🇷
General Hospital of Thessaloniki Ippokratio- 2nd Propedeutic Department of Internal Medicine, Thessaloniki, Greece
🇬🇷George Papanikolaou Hospital - Gene and Cell Therapy Center- Hematology Dpt- Hematopoietic Stem Cell Transplant Center, Thessaloniki, Greece
Clinical Outcomes of the Implementation of Diurnal IOP Curve to 1500 Patients - A Cohort Study.
Completed
- Conditions
- To Present the Clinical Outcomes of Diurnal IOP Monitoring and Determine Its Value in Our Clinical Practice
- First Posted Date
- 2022-06-02
- Last Posted Date
- 2022-06-02
- Lead Sponsor
- George Papanicolaou Hospital
- Target Recruit Count
- 1500
- Registration Number
- NCT05400759
- Prev
- 1
- 2
- 3
- Next
News
No news found